Pivotal Therapeutics (OTCPK:PVTT.F) - Stock Price, News & Analysis

PVTT.F Stock Overview

Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health.

About the company

PVTT.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

Does not have a meaningful market cap ($172K)

Shares are highly illiquid

Latest financial reports are more than a year old

Pivotal Therapeutics Inc. Competitors

Veritas Farms

OTCPK:VFRM

US$163.9k

Juva Life

OTCPK:JUVA.F

US$197.0k

CBD Life Sciences

OTCPK:CBDL

US$113.4k

Kid Castle Educational

OTCPK:KDCE

US$357.2k

Price History & Performance

Summary of all time highs, changes and price drops for Pivotal Therapeutics
Historical stock prices
Current Share Price	US$0.0018
52 Week High	US$0.0021
52 Week Low	US$0.000001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	-75.34%
5 Year Change	-48.57%
Change since IPO	-99.36%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	PVTT.F	US Pharmaceuticals	US Market
7D	0%	1.1%	0.06%
1Y	n/a	20.0%	22.6%

Return vs Industry: Insufficient data to determine how PVTT.F performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how PVTT.F performed against the US Market.

Price Volatility

Is PVTT.F's price volatile compared to industry and market?
PVTT.F volatility
PVTT.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.1%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: PVTT.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PVTT.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Rachelle MacSweeney	www.pivotaltherapeutics.us

Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels.

Pivotal Therapeutics Inc. Fundamentals Summary

How do Pivotal Therapeutics's earnings and revenue compare to its market cap?
PVTT.F fundamental statistics
Market cap	US$172.43k
Earnings (TTM)	-US$2.77m
Revenue (TTM)	US$269.82k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is PVTT.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PVTT.F income statement (TTM)
Revenue	CA$356.99k
Cost of Revenue	CA$385.17k
Gross Profit	-CA$28.17k
Other Expenses	CA$3.64m
Earnings	-CA$3.67m

Last Reported Earnings

Sep 30, 2015

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did PVTT.F perform over the long term?

See historical performance and comparison